Loading...

CVRx, Inc.

CVRXNASDAQ
Healthcare
Medical - Devices
$7.72
$0.08(1.05%)
U.S. Market opens in 30h 21m

CVRx, Inc. Fundamental Analysis

CVRx, Inc. (CVRX) shows moderate financial fundamentals with a PE ratio of -3.80, profit margin of -94.10%, and ROE of -99.33%. The company generates $0.1B in annual revenue with strong year-over-year growth of 30.53%.

Key Strengths

Cash Position37.40%
PEG Ratio-0.15
Current Ratio7.63

Areas of Concern

ROE-99.33%
Operating Margin-90.49%
We analyze CVRX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -135.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-135.1/100

We analyze CVRX's fundamental strength across five key dimensions:

Efficiency Score

Weak

CVRX struggles to generate sufficient returns from assets.

ROA > 10%
-50.87%

Valuation Score

Excellent

CVRX trades at attractive valuation levels.

PE < 25
-3.80
PEG Ratio < 2
-0.15

Growth Score

Moderate

CVRX shows steady but slowing expansion.

Revenue Growth > 5%
30.53%
EPS Growth > 10%
-33.17%

Financial Health Score

Moderate

CVRX shows balanced financial health with some risks.

Debt/Equity < 1
1.29
Current Ratio > 1
7.63

Profitability Score

Weak

CVRX struggles to sustain strong margins.

ROE > 15%
-9932.55%
Net Margin ≥ 15%
-94.10%
Positive Free Cash Flow
No

Key Financial Metrics

Is CVRX Expensive or Cheap?

P/E Ratio

CVRX trades at -3.80 times earnings. This suggests potential undervaluation.

-3.80

PEG Ratio

When adjusting for growth, CVRX's PEG of -0.15 indicates potential undervaluation.

-0.15

Price to Book

The market values CVRx, Inc. at 5.15 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.15

EV/EBITDA

Enterprise value stands at -4.80 times EBITDA. This is generally considered low.

-4.80

How Well Does CVRX Make Money?

Net Profit Margin

For every $100 in sales, CVRx, Inc. keeps $-94.10 as profit after all expenses.

-94.10%

Operating Margin

Core operations generate -90.49 in profit for every $100 in revenue, before interest and taxes.

-90.49%

ROE

Management delivers $-99.33 in profit for every $100 of shareholder equity.

-99.33%

ROA

CVRx, Inc. generates $-50.87 in profit for every $100 in assets, demonstrating efficient asset deployment.

-50.87%

Following the Money - Real Cash Generation

Operating Cash Flow

CVRx, Inc. generates limited operating cash flow of $-40.31M, signaling weaker underlying cash strength.

$-40.31M

Free Cash Flow

CVRx, Inc. generates weak or negative free cash flow of $-40.90M, restricting financial flexibility.

$-40.90M

FCF Per Share

Each share generates $-1.55 in free cash annually.

$-1.55

FCF Yield

CVRX converts -20.10% of its market value into free cash.

-20.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.80

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.15

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.15

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.59

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.29

vs 25 benchmark

Current Ratio

Current assets to current liabilities

7.63

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.99

vs 25 benchmark

ROA

Return on assets percentage

-0.51

vs 25 benchmark

ROCE

Return on capital employed

-0.56

vs 25 benchmark

How CVRX Stacks Against Its Sector Peers

MetricCVRX ValueSector AveragePerformance
P/E Ratio-3.8028.81 Better (Cheaper)
ROE-99.33%643.00% Weak
Net Margin-94.10%-44312.00% (disorted) Weak
Debt/Equity1.290.36 Weak (High Leverage)
Current Ratio7.634.50 Strong Liquidity
ROA-50.87%-17799.00% (disorted) Weak

CVRX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CVRx, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-82.49%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

91.25%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

93.46%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ